Equillium
Biotechnology leveraging deep understanding of immunobiology to develop products for autoimmune and inflammatory disorders. Learn more
Launch date
Employees
Market cap
$30.8m
Enterprise valuation
($2m) (Public information from Sep 2024)
Share price
$0.87 EQ
San Diego California (HQ)
Authorizing premium user...